Profusa Builds NVIDIA-Powered AI Portal for Continuous Biomarker Monitoring
Company expects early 2026 rollout in EEA; physician portal combines Lumee™ oxygen monitoring with NVIDIA NeMo to deliver AI-driven clinical workflows Profusa, Inc. (“Profusa” or...